Vaccination against japanese encephalitis, measles, mumps and rubella
AssigneeSanofi Pasteur Limited
InventorsEmmanuel Feroldi, Alain Bouckenooghe
Life of this patent
Estimating the term…
Abstract
The invention relates to a method of vaccinating against Japanese encephalitis (JE), measles, mumps and rubella which comprises co-administering to a patient in need, MMR vaccine and a live attenuated or inactivated cell culture derived JE vaccine.
Claims32
A live attenuated measles-mumps-rubella (MMR) vaccine for use in a method of inducing a protective immune response against Japanese encephalitis, said method comprising co-administering to a patient in need the MMR vaccine and a Japanese encephalitis (JE) vaccine which is either a live attenuated JE vaccine or an inactivated cell culture derived JE vaccine.
A Japanese encephalitis (JE) vaccine which is either a live attenuated JE vaccine or an inactivated cell culture derived JE vaccine, for use in a method of inducing a protective immune response against measles, mumps and rubella, said method comprising co-administering the Japanese encephalitis vaccine and an MMR vaccine to a patient in need.
Dependencies are inferred from the claim text.